Chairman’s Introduction and Overview: New Frontiers and Emerging Paradigms in Fracture Prevention for Postmenopausal Osteoporosis—The Evolving Landscape of Osteoprotection for High Risk Patients Mone Zaidi, MD, PhD, FRCP - Program Chairman
The Scientific Foundations and Pathophysiology of Osteoporosis: Fundamentals of Bone Remodeling and Novel Mechanisms to Inhibit Bone Resorption: Focus on Rank Ligand David W. Dempster, PhD
Capture the Fracture: Evidence- and FRAX®-Based Guidance on Risk Stratification for Fracture in Postmenopausal Women Roberto Pacifici, MD
Strengths and Limitations of Established Therapies for Osteoprotection: Balancing Efficacy Against Issues of Compliance, Tolerability, and Regimen Adherence with Bisphosphonates Stuart Silverman, MD, FACP, FACR
New Therapeutic Paradigms for Osteoporosis Management in Postmenopausal Women at High Risk of Fracture: From Mechanisms of Action to Landmark Trials Focused on Multi-Site Fracture Prevention Felicia Cosman, MD
Summary and Vision Statement: Emerging Perspectives on Fracture Prevention for High Risk, Postmenopausal Osteoporosis: Where Do We Stand? Where Are the Trials and Evidence Leading Us? Mone Zaidi, MD, PhD, FRCP – Program Chair
Interactive Question and Answer Session Faculty Panel
